» Articles » PMID: 9792318

Apparent Reactivation of a Red Cell Alloantibody in a Healthy Individual After G-CSF Administration

Overview
Journal Br J Haematol
Specialty Hematology
Date 1998 Oct 29
PMID 9792318
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Granulocyte-colony stimulating factor (G-CSF) has been successfully administered to healthy subjects to mobilize peripheral blood stem cells (PBSC) for allogeneic transplantation. Adverse events are moderate. We report the first case of apparent reactivation of an alloantibody to a blood cell antigen (Jk(a)) after G-CSF administration to a healthy subject and its transmission to the PBSC transplant recipient; no concomitant reactivation of other alloantibodies was detected. This case raises questions on the effect of G-CSF on the immune system and its safety in healthy individuals.

Citing Articles

Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.

Dunn C, Goa K Drugs. 2000; 59(3):681-717.

PMID: 10776839 DOI: 10.2165/00003495-200059030-00017.